AIFFNasdaqServices-Prepackaged SoftwareFiscal year ends December 31
FIREFLY NEUROSCIENCE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.00−0.02 (-1.96%)
Close on Oct 19, 2026
- Market cap
- $20.58M
- P/E (TTM)
- –
- Dividend yield
- –
Firefly Neuroscience statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Prepackaged Software companies for comparison
Valuation
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Market Cap | $15.69M | $283.76M |
| Enterprise Value | $6.46M | $296.20M |
| PS Ratio | 8.72 | 2.36 |
| PB Ratio | 1.07 | 2.67 |
| P/TBV Ratio | 1.80 | 4.90 |
Enterprise value
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| EV / Sales | 3.59 | 2.14 |
Income (trailing twelve months)
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Revenue | $1.80M | $289.17M |
| Gross Profit | $802.00K | $161.98M |
| Operating Income | -$9.14M | -$613.24K |
| Pretax Income | -$9.11M | -$294.07K |
| Net Income | -$9.11M | -$301.07K |
| EBITDA | -$8.94M | -$156.35K |
| EPS (Diluted) | -$0.63 | $0.00 |
Margins
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Gross Margin | 44.6% | 55.8% |
| Operating Margin | -508.1% | -1.81% |
| Pretax Margin | -506.2% | -0.50% |
| Profit Margin | -506.2% | -1.80% |
| EBITDA Margin | -496.9% | 0.60% |
Returns
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Return on Equity (ROE) | -68.1% | 0.83% |
| Return on Assets (ROA) | -57.4% | -2.82% |
| Return on Invested Capital (ROIC) | -124.3% | -0.05% |
| Return on Capital Employed (ROCE) | -62.3% | -0.44% |
Growth
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 320.3% | 9.72% |
| Revenue Growth (3Y CAGR) | -53.0% | 7.66% |
| Revenue Growth (5Y CAGR) | -39.3% | 12.4% |
Balance sheet
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.23M | $43.42M |
| Net Cash (Debt) | $9.23M | $2.04M |
| Net Cash Per Share | $0.59 | $0.15 |
| Equity (Book Value) | $14.66M | $52.29M |
| Book Value Per Share | $0.93 | $1.93 |
| Tangible Book Value | $8.70M | $3.06M |
| Working Capital | $8.13M | $15.22M |
Financial position
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Current Ratio | 4.87 | 1.40 |
| Quick Ratio | 4.49 | 0.94 |
Cash flow (trailing twelve months)
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.99M | $8.52M |
Efficiency
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Asset Turnover | 0.11 | 0.64 |
| Inventory Turnover | 11.27 | 13.06 |
| Revenue Per Employee | $105.82K | $392.99K |
| Profits Per Employee | -$535.71K | -$4.47K |
| Employee Count | 17 | 531 |
Dividends and yields
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Earnings Yield | -58.0% | -0.92% |
Shares
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Shares Outstanding | 15,690,300 | 58,826,100 |
| Shares Change (YoY) | 66.4% | 2.21% |
| Shares Change (QoQ) | 5.50% | 0.06% |
| Float | 13,313,600 | 52,938,050 |
| Shares Held by Insiders | 15.1% | 13.2% |
| Shares Held by Institutions | 10.0% | 66.9% |
Taxes
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Income Tax | $1.00K | $1.69M |
Scores
| Measure | Firefly Neuroscience | Industry median |
|---|---|---|
| Altman Z-Score | -6.29 | 1.50 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | 1.03 | -2.80 |
Calculated by StockData from Firefly Neuroscience's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.